Thyroid nodule evaluations represent one of the most frequent clinical encounters in modern endocrine and general surgical practices. Diagnostic evaluation regularly mandates an ultrasound-guided fine-needle aspiration to rule out thyroid malignancy. However, patients frequently experience marked discomfort, anxiety, and fear during these ambulatory interventions. To mitigate patient distress without systemic pharmacotherapy, clinicians are increasingly exploring nonpharmacological options. A recent open-label randomized controlled trial examined the efficacy of a virtual reality thyroid biopsy approach in alleviating procedural distress. This article evaluates the physiological rationale, statistical nuances, and clinical implications of immersive technology during outpatient thyroid diagnostic procedures.

Procedural Distress and the Role of Virtual Reality Thyroid Biopsy

Thyroid fine-needle aspiration biopsy remains the reference standard for evaluating indeterminate nodules. Although operators consider the procedure minimally invasive, patient apprehension often remains high. The anterior neck represents a particularly vulnerable anatomic site. Consequently, inserting needles into this delicate region triggers acute distress, vasovagal responses, and heightened pain perception. In addition, procedural distress can induce unexpected neck movement, which impairs biopsy accuracy and increases procedural duration. Traditionally, clinicians manage discomfort using local anesthetics. However, local infiltration does not resolve psychological apprehension, emotional fear, or the visceral sensation of pressure. Therefore, modern ambulatory suites seek noninvasive strategies to optimize patient comfort. Virtual reality provides immersive sensory redirection that commands high attentional bandwidth. In theory, immersion diverts cognitive processing away from ambient clinical stimuli, such as needles and ultrasound transducers. By engaging pain gate mechanisms in the central nervous system, digital distraction can modulate subjective nociception. As a result, interventional teams hope digital tools will smooth clinical workflows and improve patient satisfaction.

Methodological Framework and Trial Design in Thyroid FNAB

To test this digital distraction hypothesis, clinical investigators initiated an open-label randomized controlled trial at Gaziantep City Hospital in Türkiye. The clinical team recruited 100 adult patients presenting with suspected thyroid nodules requiring diagnostic biopsy. Subsequently, researchers randomly allocated participants in an equal ratio to either an intervention group receiving immersive virtual reality or a control group. The primary endpoint measured postprocedural pain using the Visual Analog Scale. Secondary endpoints assessed procedural anxiety using the Beck Anxiety Inventory and subjective apprehension using the Fear of Pain Questionnaire-III. During the intervention, patients in the experimental arm wore commercial immersive headsets displaying relaxing audiovisual environments throughout needle placement. Meanwhile, control participants received standard procedural care without visual distraction. Investigators recorded baseline clinical features, previous thyroid diagnoses, and voice changes to identify potential confounding variables. Ultimately, this parallel-group methodology provided an objective clinical framework to test whether immersive sensory redirection attenuates patient discomfort during delicate outpatient neck interventions.

Primary and Secondary Outcomes: Statistical Realities

The clinical trial generated nuanced findings that demand careful analytical appraisal. When evaluating the primary outcome, the adjusted statistical analysis showed a statistically significant benefit for the digital intervention. Specifically, the virtual reality group demonstrated lower postintervention pain scores compared with the control group. The adjusted mean pain score reached 3.627 in the headset cohort versus 4.493 in the control cohort. This difference met conventional statistical significance thresholds with a p-value of 0.048. However, the unadjusted between-group comparison failed to demonstrate statistical significance, yielding a p-value of 0.12. Furthermore, the unadjusted effect size remained small, with a 95% confidence interval crossing zero. Similarly, secondary outcomes did not demonstrate meaningful between-group separation. The adjusted comparison for anxiety revealed no statistically significant divergence, generating a p-value of 0.48. Likewise, fear of pain scores showed no statistically significant reduction between groups, recording a p-value of 0.07. Standardized effect sizes for anxiety and fear of pain remained notably weak throughout post-hoc evaluations.

Clinical Interpretation of Covariate Adjustments and Statistical Power

Physicians must interpret these experimental findings with appropriate methodological skepticism. Statistical significance emerged exclusively after investigators adjusted for baseline pain, prior thyroid mass diagnoses, and voice changes. Notably, researchers selected two of these covariates post-hoc due to observed baseline imbalances rather than prespecifying them in the initial protocol. Such post-hoc statistical adjustments can artificially optimize p-values and increase the risk of false-positive discoveries. Moreover, the trial suffered from clear statistical power constraints. The authors documented an observed adjusted effect size of 0.207. However, the original power calculations mandated a minimum effect size of 0.283 to ensure adequate statistical power. Consequently, the trial was mathematically underpowered to confirm small clinical benefits reliably. While virtual reality caused no physiological harm, it did not demonstrate robust, unadjusted superiority over standard clinical practice. Therefore, clinicians should view virtual reality as an exploratory adjunct rather than a proven therapeutic analgesic. Larger multi-center studies with rigorous prospective blinding protocols are essential to clarify these ambiguous observations.

Practical Implementation and Future Directions for Ambulatory Practice

Despite equivocal statistical outcomes, digital interventions remain an attractive avenue for modern ambulatory healthcare systems. In clinical practice, patient tolerance and satisfaction often encompass qualitative elements that numerical pain scales capture imperfectly. Many patients report subjective relaxation and reduced situational distress when using immersive headsets during needle interventions. However, practical implementation presents logistical hurdles for busy diagnostic clinics. Headsets require thorough antimicrobial sanitization between patients to prevent healthcare-associated infections. Furthermore, clinicians must ensure that headset straps do not interfere with neck positioning or ultrasound probe manipulation. Device procurement costs, software licenses, and staff training also represent non-trivial financial investments for healthcare institutions. Moving forward, clinical researchers should focus on identifying specific patient phenotypes that derive maximal benefit from digital sedation. For instance, individuals with severe needle phobia or documented prior procedural trauma may achieve substantial relief. Until high-powered confirmatory trials provide definitive evidence, clinics should adopt virtual systems selectively, integrating them thoughtfully alongside established local anesthetic standards.

Frequently Asked Questions

Does immersive technology eliminate the requirement for local anesthesia during biopsy?

No, virtual reality cannot replace local anesthetics during needle biopsy procedures. Clinicians utilize immersive digital environments primarily as adjunctive distraction therapy. Although the technology modifies cognitive processing and subjective sensory appraisal, it does not interrupt peripheral nociceptive pathways. Consequently, healthcare practitioners should continue standard local anesthesia protocols to ensure adequate sensory numbing, using immersive tools purely to enhance patient emotional comfort and overall procedural tolerance.

Why did unadjusted and adjusted statistical models yield different pain findings?

Statistical models diverged because researchers accounted for baseline procedural pain, prior nodule history, and clinical voice changes during covariate adjustment. Unadjusted comparisons lacked sufficient power to reach statistical significance across fifty patient cohorts. Furthermore, adjusting for post-randomization imbalances artificially lowered the residual variance, nudging the probability value just under significance thresholds. Consequently, clinicians must interpret these borderline findings cautiously until larger, rigorously prespecified confirmatory clinical trials validate the true effect size.

Which outpatient clinical settings benefit most from virtual distraction techniques?

Outpatient diagnostic suites performing minimally invasive interventions benefit significantly from digital distraction systems. Specifically, thyroid clinics, interventional radiology suites, and ambulatory breast centers frequently encounter high baseline procedural distress. Patients with pronounced needle phobia or situational apprehension experience the greatest nonpharmacological relief. However, facilities must consider initial procurement expenditures, equipment sanitization between patients, and clinician training before embedding immersive headsets into routine, high-volume ambulatory clinical workflows.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult qualified healthcare professionals before implementing novel clinical interventions. Refer to the latest local and national guidelines for clinical practice.

References

Karadeniz E et al. Effects of Virtual Reality on Pain, Anxiety, and Fear During Thyroid Fine-Needle Aspiration Biopsy: Open-Label Randomized Controlled Trial. J Med Internet Res. 2026 Oct 06. doi: 10.2196/103829. PMID: 42837655.

Schaake R, et al. Virtual Reality for the Management of Pain and Anxiety for IR Procedures: A Prospective, Randomized, Pilot Study on Digital Sedation. J Vasc Interv Radiol. 2024;35(7):1010-1017.

Ding H, et al. The efficacy of virtual reality in adults during puncture biopsy: A systematic review and meta-analysis of randomized controlled trials. Heliyon. 2025;11(16):e36492.